Top Tweets for #AMPLIGEN
Wir brauchen wirksame Medikamente, keine Erlaubnis zum Selbstmord. #BC007 #Ampligen #MECFS #LongCovid #PostVAC
🧐1987 Kariko et al.:
„KLINISCHE, IMMUNOLOGISCHE UND VIROLOGISCHE WIRKUNGEN VON AMPLIGEN, EINER MISMATCHED-DOPPELSTRANG-RNA, BEI PATIENTEN MIT AIDS ODER EINEM AIDS-ASSOZIIERTEN SYNDROM“
Wirksamkeit von #Ampligen bei #MEcfs längst bekannt!
#MEcfs war mal als #nonHIVaids bekannt...
"CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX" (1987)
@andrewcaravello $nwbo @alphavestcap
moreheadline is the spark. The linked Ebola essay is the blueprint. They are two different things. The Yahoo/AIM headline points to #Ampligen and the emerging #Ebola opportunity. The Ebola essay explains why$NWBO #DCVax #AdventBioservices #Ebola$AIM#Ampligen The Yahoo$AIM📷Andrew Caravello, DO@andrewcaravello·32sImmunoTech Announces Emerging Ebola Opportunity for #Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration https://t.co/WTJtPxv4d4 #DCVax #AdventBioservices #Ebola$AIMThe Yahoo$AIMheadline is the spark. The linked Ebola essay is the blueprint. They are two different things. The Yahoo/AIM headline points to #Ampligen and the emerging #Ebola opportunity. The Ebola essay explains why that opportunity fits a much larger immune architecture. #Bundibugyo Ebola is not simply an antigen problem. It is an immune-instruction problem. Ebola brings the viral lesson with the silencer attached. The host can be flooded with antigen, danger, inflammation, and tissue injury, yet still fail to convert that signal into disciplined cellular immunity if the dendritic-cell instructor is disabled before the lesson can be taught. That is the teacher problem. This is where the broader $NWBO #DCVax logic becomes relevant, not as a claim about an approved Ebola product, but as the dendritic-cell instruction thesis itself. Build the immune teacher outside the corrupted viral field. Load the viral curriculum without the silencer. Preserve autologous HLA presentation. Verify IL-12p70 competence. Restore CD4 licensing. Prime CD8 killing. Activate NK support. Reinforce IFN-gamma. Write memory. That is the instruction layer. And once the instruction layer exists, manufacturing discipline matters. That is why #AdventBioservices belongs in the conversation: GMP cell-therapy execution is what turns dendritic-cell instruction from concept into regulated clinical reality. But the Ebola essay also identifies the second layer. The instructor returns to a classroom. Ebola does not only disable dendritic cells. It distorts the antiviral field around them: interferon tone, myeloid activation, chemokine output, NK readiness, and the viral-RNA sensing environment needed for the lesson to propagate. That is where$AIMand Ampligen fit. Ampligen is not the vaccine. Ampligen is not the antigen. Ampligen is not the dendritic-cell instructor. Ampligen is the viral-RNA classroom signal. AIM describes Ampligen as a double-stranded RNA immunomodulator that activates TLR3 through the TRIF adaptor while avoiding the broader systemic inflammatory MyD88 pathway used by many other Toll-like receptors. That distinction matters. Ebola already creates inflammatory chaos. The missing signal is not louder immune noise. The missing signal is governed antiviral context. That is why the Yahoo/AIM headline matters. It did not create the thesis. It surfaced the classroom layer the Ebola essay had already described. The BSL-4 preclinical Ebola data are the clue. The architecture is the story. $NWBO #DCVax represents the dendritic-cell instruction thesis. #AdventBioservices represents the GMP execution layer.$AIMAmpligen represents the antiviral classroom signal. The Bundibugyo curriculum supplies the lesson. IL-12p70 supplies the license. CD8, NK, IFN-gamma, and memory supply execution. Teacher. Classroom. Curriculum. License. Execution. That is the architecture. A complete countermeasure strategy cannot only deliver antigen. It has to restore the system that teaches antigen what to become. 🔗 https://t.co/iD2FpYnCpV
$NWBO #DCVax #AdventBioservices #Ebola $AIM #Ampligen
The Yahoo $AIM headline is the spark.
The linked Ebola essay is the blueprint.
They are two different things.
The Yahoo/AIM headline points to #Ampligen and the emerging #Ebola opportunity.
The Ebola essay explains why that opportunity fits a much larger immune architecture.
#Bundibugyo Ebola is not simply an antigen problem.
It is an immune-instruction problem.
Ebola brings the viral lesson with the silencer attached.
The host can be flooded with antigen, danger, inflammation, and tissue injury, yet still fail to convert that signal into disciplined cellular immunity if the dendritic-cell instructor is disabled before the lesson can be taught.
That is the teacher problem.
This is where the broader $NWBO #DCVax logic becomes relevant, not as a claim about an approved Ebola product, but as the dendritic-cell instruction thesis itself.
Build the immune teacher outside the corrupted viral field.
Load the viral curriculum without the silencer.
Preserve autologous HLA presentation.
Verify IL-12p70 competence.
Restore CD4 licensing.
Prime CD8 killing.
Activate NK support.
Reinforce IFN-gamma.
Write memory.
That is the instruction layer.
And once the instruction layer exists, manufacturing discipline matters.
That is why #AdventBioservices belongs in the conversation: GMP cell-therapy execution is what turns dendritic-cell instruction from concept into regulated clinical reality.
But the Ebola essay also identifies the second layer.
The instructor returns to a classroom.
Ebola does not only disable dendritic cells. It distorts the antiviral field around them: interferon tone, myeloid activation, chemokine output, NK readiness, and the viral-RNA sensing environment needed for the lesson to propagate.
That is where $AIM and Ampligen fit.
Ampligen is not the vaccine.
Ampligen is not the antigen.
Ampligen is not the dendritic-cell instructor.
Ampligen is the viral-RNA classroom signal.
AIM describes Ampligen as a double-stranded RNA immunomodulator that activates TLR3 through the TRIF adaptor while avoiding the broader systemic inflammatory MyD88 pathway used by many other Toll-like receptors.
That distinction matters.
Ebola already creates inflammatory chaos.
The missing signal is not louder immune noise.
The missing signal is governed antiviral context.
That is why the Yahoo/AIM headline matters.
It did not create the thesis.
It surfaced the classroom layer the Ebola essay had already described.
The BSL-4 preclinical Ebola data are the clue.
The architecture is the story.
$NWBO #DCVax represents the dendritic-cell instruction thesis.
#AdventBioservices represents the GMP execution layer.
$AIM Ampligen represents the antiviral classroom signal.
The Bundibugyo curriculum supplies the lesson.
IL-12p70 supplies the license.
CD8, NK, IFN-gamma, and memory supply execution.
Teacher.
Classroom.
Curriculum.
License.
Execution.
That is the architecture.
A complete countermeasure strategy cannot only deliver antigen.
It has to restore the system that teaches antigen what to become.
🔗
https://t.co/HWsx56ViIO
$AIM ImmunoTech Announces Emerging Ebola Opportunity for #Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
🔗
https://t.co/qRZFCTcrKE
https://t.co/l3vaz7thQY
@verenabee @Lillikarina2022 JEDER Arzt würde #MEcfs behandeln, WENN es zugel. Medikamente geben würde.
Aber genau daran hakt es seit Dekaden!
Das ist kein Zufall.
#BC007, #Ampligen, #IVIG, #ART etc. sind längst entwickelt & es hilft einem Teil der #pwME, trotzdem keine Zulassung.
https://t.co/FbeObLVPcy
@C_Scheibenbogen Und die, die keine lange Überlebenszeit mehr haben?Die am schwersten erkrankten #MEcfs Patienten kann nur eine sofortige Notzulassung o. experimentelle Gabe von schon entwickelten Medikamenten, wie #BC007, #Ampligen... retten!
Statt Palliativ/SAPV!
Medicijn goedgekeurd in Argentinië om #MEcfs mee te behandelen nu klaar voor Europese longcovid trials.
AIM ImmunoTech Announces European Patent Office Grants Patent Covering #Ampligen / #Rintatolimod for Use in the Treatment of #LongCovid
https://t.co/zSgGGQKrvc
Yet another letdown. Aim ImmunoTech is no longer working with myTomorrows, the org which helped facilitate access to #Ampligen.
cc: @JohannaBorde @useless_priest @MECFScomrade
@Ramyisback
@Karl_Lauterbach
@JBerlin17207
@ddell36455907
@Caitshith @makemevisible24 I've rec'd a response from the org that facilitated access to #Ampligen
"Unfortunately, AIM ImmunoTech, the sponsor are no longer working with myTomorrows in providing Ampligen expanded access program (EAP) anymore."
@mecfsskeptic
@tiredguineapig
@MECFSNanoneedle
@Catinmyfamily
@Caitshith @makemevisible24 I've rec'd a response from the org that facilitated access to #Ampligen
"Unfortunately, AIM ImmunoTech, the sponsor are no longer working with myTomorrows in providing Ampligen expanded access program (EAP) anymore."
@mecfsskeptic
@tiredguineapig
@MECFSNanoneedle
@Catinmyfamily
In 2012, #Ampligen was denied approval as a #MECFS treatment because there is no diagnostic blood test for ME/CFS. A ME/CFS diagnostic test is science, not science fiction.
You can do a #socialgood by Donating Directly to #MECFS Biomarker Studies
👉 https://t.co/FWFpbNfqUG
@GoeringEckardt Aufmerksamkeit alleine wird weitere #MEcfs Sterbefälle leider nicht verhindern, bitte setzen Sie sich dafür ein, dass endlich Medikamente verfügbar werden!
Genauso wie Krebspatienten experimentelle Therapien angeboten werden, muss #BC007 #Ampligen #IVIG etc. ermöglicht werden!
2/2
Traurig, dass statt wirksamen Therapien, wie #BC007 #Ampligen, #IVIG, #Apherese,... speziell zugeschnitten auf den Patient, heute im Schnelldurchlauf #Sterbehilfe genehmigt wird.
Scheinbar geht es in🇩🇪nur noch um die Kosten, die ein Kranker verursacht, nicht um den Mensch.
@sarah_buckel 🫂💔I am simply shocked that our health system in Germany does not allow experimental treatments like #BC007 #Ampligen #IVIG #ART but does allow euthanasia after such a short but extremely serious illness.
⚠️#TheyLetMEdie
@PeeNee2 @Dr_B_Hohberger Inderdaad. #BC007 Begint zo een beetje op de #Ampligen controverse te lijken.
Werkt wel... Werkt niet, verkeerde trial dosis.... vertrouwen zoek en nog steeds niet goed onderzocht.
Daar is niemand bij gebaat.
Last Seen Hashtags on Sotwe
anxiouspandaa(***********) filter:native_video
Seen from United States
Karenfisher
Seen from India
cuckold
Seen from United Kingdom
omegle() filter:videos
Seen from Kuwait
فطوم_سلطانة
Seen from Germany
MGAI
Seen from Puerto Rico
teacher() fuck()+filter:videos
Seen from Pakistan
beerpassaranan
Seen from France
plaping
Seen from Turkey
StrangersOnline
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers